Anticoagulant therapy for percutaneous coronary intervention.
Publication
, Journal Article
Rao, SV; Ohman, EM
Published in: Circ Cardiovasc Interv
February 1, 2010
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circ Cardiovasc Interv
DOI
EISSN
1941-7632
Publication Date
February 1, 2010
Volume
3
Issue
1
Start / End Page
80 / 88
Location
United States
Related Subject Headings
- Thrombin
- Recombinant Proteins
- Postoperative Complications
- Polysaccharides
- Platelet Activation
- Peptide Fragments
- Myocardial Ischemia
- Humans
- Hirudins
- Fondaparinux
Citation
APA
Chicago
ICMJE
MLA
NLM
Rao, S. V., & Ohman, E. M. (2010). Anticoagulant therapy for percutaneous coronary intervention. Circ Cardiovasc Interv, 3(1), 80–88. https://doi.org/10.1161/CIRCINTERVENTIONS.109.884478
Rao, Sunil V., and E Magnus Ohman. “Anticoagulant therapy for percutaneous coronary intervention.” Circ Cardiovasc Interv 3, no. 1 (February 1, 2010): 80–88. https://doi.org/10.1161/CIRCINTERVENTIONS.109.884478.
Rao SV, Ohman EM. Anticoagulant therapy for percutaneous coronary intervention. Circ Cardiovasc Interv. 2010 Feb 1;3(1):80–8.
Rao, Sunil V., and E. Magnus Ohman. “Anticoagulant therapy for percutaneous coronary intervention.” Circ Cardiovasc Interv, vol. 3, no. 1, Feb. 2010, pp. 80–88. Pubmed, doi:10.1161/CIRCINTERVENTIONS.109.884478.
Rao SV, Ohman EM. Anticoagulant therapy for percutaneous coronary intervention. Circ Cardiovasc Interv. 2010 Feb 1;3(1):80–88.
Published In
Circ Cardiovasc Interv
DOI
EISSN
1941-7632
Publication Date
February 1, 2010
Volume
3
Issue
1
Start / End Page
80 / 88
Location
United States
Related Subject Headings
- Thrombin
- Recombinant Proteins
- Postoperative Complications
- Polysaccharides
- Platelet Activation
- Peptide Fragments
- Myocardial Ischemia
- Humans
- Hirudins
- Fondaparinux